Disc Medicine, Inc. (IRON)
58.17
-1.00
(-1.69%)
USD |
NASDAQ |
Mar 20, 16:00
58.17
0.00 (0.00%)
After-Hours: 20:00
Disc Medicine Research and Development Expense (Quarterly) : 46.14M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Eli Lilly & Co. | 3.802B |
| Boston Scientific Corp. | 569.00M |
| Penumbra, Inc. | 17.52M |
| Amylyx Pharmaceuticals, Inc. | 21.10M |
| Emergent BioSolutions, Inc. | 12.10M |